2010至2022年美国国家乳腺摄影数据库中筛查性与诊断性乳腺摄影的假阴性
该回顾性研究纳入2010年1月1日至2022年12月31日美国国家乳腺摄影数据库的全部筛查性与诊断性乳腺摄影,假阴性定义为检查阴性且其后一年内组织学诊断乳腺癌。筛查性假阴性率为1.9/1000次检查,诊断性为4.0/1000次检查;多因素分析显示假阴性率与患者种族、乳腺密度、个人或家族乳腺癌史及学术机构等因素相关。
要点
- 筛查性乳腺摄影假阴性率1.9/1000次检查,诊断性为4.0/1000次检查。
- 非几乎全脂肪型乳腺密度者假阴性风险更高,筛查OR 1.60-2.00,诊断OR 1.50-2.78。
- 有个人乳腺癌史者假阴性风险更高,筛查OR 3.69,诊断OR 7.82。
核心结论
- 筛查性与诊断性乳腺摄影的假阴性率随时间上升,且与患者及机构特征存在显著关联(原文表述为significant associations)。
研究设计与样本
- 回顾性研究,纳入美国国家乳腺摄影数据库2010年1月1日至2022年12月31日全部筛查性与诊断性乳腺摄影,共38,304,525次检查、15,585,433名女性(平均年龄64.4±10.8岁);假阴性定义为检查阴性且其后一年内组织学诊断乳腺癌。
诊断标准与关键数值
- 筛查性检查32,267,238次,假阴性率1.9/1000次检查(最低0.7,见于2010年;最高2.5,见于2020至2022年各年)。
- 诊断性检查6,037,287次,假阴性率4.0/1000次检查(最低2.3,见于2010年;最高5.4,见于2020年)。
- 筛查性检查多因素分析:非白人种族OR 0.30-0.95;非几乎全脂肪型乳腺密度OR 1.60-2.00;个人乳腺癌史OR 3.69;家族乳腺癌史OR 1.29;学术或大学附属机构OR 1.37。
- 诊断性检查多因素分析:亚裔OR 0.91;夏威夷裔OR 0.77;黑人OR 1.12;西班牙裔OR 0.70;非几乎全脂肪型乳腺密度OR 1.50-2.78;个人乳腺癌史OR 7.82;家族乳腺癌史OR 1.31;学术或大学附属机构OR 1.37。
临床应用与阅片要点
- 原文结论指出,探索所观察关联的原因可为质量保证工作提供信息,以降低乳腺癌诊断延迟的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. False-negative (FN) mammograms typically delay breast cancer diagnoses and may impact clinical outcomes. However, systematic evaluations of FN mammograms are challenging to conduct due to the low incidence of interval cancers. OBJECTIVE. The purpose of this study was to evaluate the rates of FN screening and diagnostic mammograms in the NMD and to assess associations of FN rates with patient- and facility-level characteristics. METHODS. This retrospective study included all screening and diagnostic mammograms in the National Mammography Database (NMD) obtained from January 1, 2010, to December 31, 2022. Patient- and facility-level factors were extracted from the NMD. FN mammograms were defined as those with a negative result in a patient with a tissue diagnosis of breast cancer within the subsequent year. FN rates per 1000 examinations were computed. Separate multivariable analyses were performed to identify associations with FN results for screening and diagnostic examinations. RESULTS. The analysis included 38,304,525 mammography examinations for 15,585,433 women (mean [SD] age, 64.4 ± 10.8 years). For 32,267,238 screening examinations, the FN rate was 1.9 (minimum, 0.7 in 2010; maximum, 2.5 in each year from 2020 to 2022). For 6,037,287 diagnostic examinations, the FN rate was 4.0 (minimum, 2.3 in 2010; maximum, 5.4 in 2020). In multivariable analysis, for screening examinations, the likelihood of an FN examination was lower for patients with race categories other than White (OR = 0.30-0.95), higher for patients with breast density categories other than almost entirely fatty breasts (OR = 1.60-2.00), higher for women with a personal (OR = 3.69) or family (OR = 1.29) history of breast cancer, and higher for academic or university-based facilities (OR = 1.37); for diagnostic examinations, the likelihood of an FN examination was lower for patients with race categories of Asian (OR = 0.91) and Hawaiian (OR = 0.77) and higher for patients with a race category of Black (OR = 1.12), lower for Hispanic patients (OR = 0.70), higher for patients with breast density categories other than almost entirely fatty breasts (OR = 1.50-2.78), higher for women with a personal (OR = 7.82) or family (OR = 1.31) history of breast cancer, and higher for academic or university-based facilities (OR = 1.37). CONCLUSION. Rates of FN screening and diagnostic mammograms increased over time and showed significant associations with patient and facility characteristics. CLINICAL IMPACT. Exploration of the causes of the observed associations could inform quality assurance efforts to reduce the risk of delayed breast cancer diagnoses.
引用
- Oluyemi ET, Grimm LJ, Goldman L, et al. False-Negative Screening and Diagnostic Mammograms in the National Mammography Database From 2010 to 2022. AJR Am J Roentgenol. 2026. PMID: 41123961. doi:10.2214/AJR.25.33636
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。